CRABP1 and pancreatic ductal adenocarcinoma: “(D) Compounds lose ability to induce ERK activity in human CRABP1 null cancer cell line A2780 (ovarian) and mouse KPC (pancreatic ductal carcinoma) after 100 nM, 30 min treatment (upper).